Genelux Corporation (GNLX) Total Return Calculator with Dividends Reinvested

Genelux Corporation

Popular:

The total return for Genelux Corporation (GNLX) stock is +1.54% over the past 12 months. So far it's down 34.84% this year. The 5-year total return is -51.79%, meaning $10,000 invested in GNLX stock 5 years ago would be worth $4,821 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in GNLX 1 year ago, it would be worth $9,983 today — you'd have lost $17.

With Dividends Reinvested$9,983-0.17%

Price Only (No DRIP)$9,983-0.17%

Period2025-06-20 → 2026-06-18

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in GNLX

1Y$10,154+$154 (+1.5%)1.5% CAGR

3Y$806-$9,194 (-91.9%)-56.8% CAGR

5Y$4,821-$5,179 (-51.8%)-13.6% CAGR

10Y$4,821-$5,179 (-51.8%)-7.0% CAGR

15Y$4,821-$5,179 (-51.8%)-4.7% CAGR

20Y$4,821-$5,179 (-51.8%)-3.6% CAGR

30Y$4,821-$5,179 (-51.8%)-2.4% CAGR

Genelux Corporation did not pay dividends during this period. Total return = price return.

Loading GNLX total return...

As of 2026-06-20

Returns at a Glance

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	-34.84%	—	-34.84%	—	$6,516
1Y	+1.54%	1.54%	+1.54%	—	$10,154
3Y	-91.94%	-56.81%	-91.94%	—	$806
5Y	-51.79%	-13.58%	-51.79%	—	$4,821
10Y	-51.79%	-7.04%	-51.79%	—	$4,821
15Y	-51.79%	-4.75%	-51.79%	—	$4,821
20Y	-51.79%	-3.58%	-51.79%	—	$4,821
30Y	-51.79%	-2.40%	-51.79%	—	$4,821

Risk & Highlights

Best Year+127.80%2023

Worst Year-84.11%2024

Max Drawdown-72.09%2025-11-03 → 2026-03-30

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	-34.51%	-34.51%	—	+0.41%	-34.9pp
2025	+80.91%	+80.91%	—	+16.64%	+64.3pp
2024	-84.11%	-84.11%	—	+24.00%	-108.1pp
2023	+127.80%	+127.80%	—	+24.81%	+103.0pp

GNLX underperformed the S&P 500 by 23.45pp over the past year (+1.54% vs +24.99%).

Loading summary...

GNLX Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
GNLXGenelux Corporation	$112M	+4.0%	-34.8%	+1.5%	—	-91.9%	-51.8%	-51.8%
IMVTImmunovant, Inc.	$7.3B	+33.2%	+36.4%	+122.8%	—	+77.8%	+214.7%	+255.2%
TGTXTG Therapeutics, Inc.	$8.1B	+34.8%	+81.8%	+51.3%	—	+119.7%	+41.7%	+658.1%
KRYSKrystal Biotech, Inc.	$10.3B	+19.3%	+41.0%	+163.5%	—	+179.0%	+433.0%	+3171.2%
ADCTADC Therapeutics S.A.	$139M	-65.6%	-69.0%	-64.0%	—	-52.2%	-95.3%	-96.3%
VVOSVivos Therapeutics, Inc.	$3M	-16.5%	-80.2%	-79.8%	—	-96.1%	-99.6%	-99.8%
IMCRImmunocore Holdings plc	$1.5B	+0.8%	-15.3%	-9.8%	—	-52.8%	-30.2%	-33.8%
CLDXCelldex Therapeutics, Inc.	$2.2B	+7.3%	+20.1%	+55.8%	—	-11.9%	+16.7%	-51.0%
NKTRNektar Therapeutics	$1.2B	-10.9%	+40.4%	+608.2%	—	+639.2%	-76.1%	-73.3%
AGENAgenus Inc.	$125M	-5.1%	-7.1%	-32.9%	—	-92.0%	-97.1%	-96.4%
SNDXSyndax Pharmaceuticals, Inc.	$1.7B	-2.1%	-10.8%	+96.1%	—	-11.3%	-1.2%	+51.4%

Compare:GNLX vs IMVT GNLX vs TGTX GNLX vs KRYS GNLX vs IMVT vs TGTX

About GNLX Dividend Returns

Genelux Corporation (GNLX) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of GNLX over the past year?

Genelux Corporation (GNLX) delivered a return of 1.54% over the past year. Since GNLX does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in GNLX be worth today?

A $10,000 investment in Genelux Corporation one year ago would be worth $10,154 today, representing a gain of $154.

Q3Does GNLX pay dividends?

Genelux Corporation (GNLX) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For GNLX, the total return equals the price-only return.

Q4Did GNLX beat the S&P 500?

No, Genelux Corporation (GNLX) underperformed the S&P 500 by 23.45 percentage points over the past year. GNLX delivered a total return of 1.54%, compared to the S&P 500's 24.99%. This means a passive S&P 500 index fund outperformed GNLX by 23.45pp during this period.

Q5What is GNLX's worst drawdown?

Genelux Corporation (GNLX) experienced a maximum drawdown of -72.09% over the past year, declining from its peak on 2025-11-03 to its trough on 2026-03-30. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is GNLX's long-term total return over 10, 20, or 30 years?

Here are Genelux Corporation (GNLX)'s long-term returns with dividends reinvested. Over 10 years, the total return is -51.8% (-7.0% CAGR) — $10,000 would have grown to $4,821. Over 20 years: -51.8% total return (-3.6% CAGR) — $10,000 → $4,821. Over 30 years: -51.8% total return (-2.4% CAGR) — $10,000 → $4,821. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was GNLX's best and worst year?

Genelux Corporation's best calendar year was 2023 with a total return of 127.8%. Its worst year was 2024 with a total return of -84.1%. This range shows the volatility investors should expect — the difference between the best and worst year is 211.9 percentage points.

How much would $100/month in GNLX be worth today?

Dollar cost averaging calculator · DCA vs lump sum · see how regular investing compounds

Run the Numbers →